Susquehanna International Group, LLP Gilead Sciences, Inc. Transaction History

Susquehanna International Group, LLP

$560 Billion
Q3 2024

A detailed history of Susquehanna International Group, LLP transactions in Gilead Sciences, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 286,199 shares of GILD stock, worth $25.7 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

286,199

Previous 417,416 31.44%

Holding current value

$25.7 Million

Previous $28.6 Million 16.23%

% of portfolio

0.0%

Previous 0.01%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$66.59 - $83.99 $8.74 Million - $11 Million	-131,217 Reduced 31.44%	286,199 $24 Million
Q2 2024 Aug 15, 2024	BUY	$63.15 - $72.88 $2.58 Million - $2.98 Million	40,826 Added 10.84%	417,416 $28.6 Million
Q1 2024 May 07, 2024	SELL	$71.58 - $87.29 $14 Million - $17.1 Million	-195,565 Reduced 34.18%	376,590 $27.6 Million
Q4 2023 Feb 14, 2024	BUY	$73.27 - $83.09 $6.89 Million - $7.81 Million	94,038 Added 19.67%	572,155 $46.4 Million
Q3 2023 Nov 14, 2023	SELL	$73.94 - $80.67 $16.5 Million - $18 Million	-222,857 Reduced 31.79%	478,117 $35.8 Million
Q2 2023 Aug 11, 2023	SELL	$76.01 - $86.7 $20.3 Million - $23.2 Million	-267,683 Reduced 27.63%	700,974 $54 Million
Q1 2023 May 16, 2023	BUY	$77.31 - $88.08 $18.1 Million - $20.6 Million	234,360 Added 31.92%	968,657 $80.4 Million
Q4 2022 Feb 14, 2023	SELL	$62.32 - $89.47 $1.59 Million - $2.28 Million	-25,466 Reduced 3.35%	734,297 $63 Million
Q3 2022 Nov 14, 2022	BUY	$59.54 - $68.01 $12.4 Million - $14.1 Million	208,000 Added 37.7%	759,763 $46.9 Million
Q2 2022 Aug 15, 2022	SELL	$57.72 - $65.01 $62.6 Million - $70.5 Million	-1,084,222 Reduced 66.27%	551,763 $34.1 Million
Q1 2022 May 16, 2022	BUY	$57.92 - $72.58 $67 Million - $83.9 Million	1,156,450 Added 241.16%	1,635,985 $97.3 Million
Q4 2021 Feb 14, 2022	SELL	$64.88 - $73.64 $229 Million - $260 Million	-3,524,168 Reduced 88.02%	479,535 $34.8 Million
Q3 2021 Nov 15, 2021	BUY	$67.69 - $73.03 $35.4 Million - $38.2 Million	522,678 Added 15.02%	4,003,703 $280 Million
Q2 2021 Aug 11, 2021	BUY	$63.47 - $69.35 $18.1 Million - $19.7 Million	284,753 Added 8.91%	3,481,025 $240 Million
Q1 2021 May 17, 2021	SELL	$60.0 - $68.46 $331 Million - $377 Million	-5,510,839 Reduced 63.29%	3,196,272 $207 Million
Q4 2020 Feb 16, 2021	BUY	$56.65 - $64.55 $146 Million - $166 Million	2,577,017 Added 42.04%	8,707,111 $507 Million
Q3 2020 Nov 16, 2020	BUY	$62.1 - $78.08 $154 Million - $194 Million	2,480,735 Added 67.98%	6,130,094 $387 Million
Q2 2020 Aug 14, 2020	SELL	$72.34 - $84.0 $68.9 Million - $80 Million	-951,933 Reduced 20.69%	3,649,359 $281 Million
Q1 2020 May 15, 2020	SELL	$62.63 - $80.22 $32.6 Million - $41.7 Million	-520,427 Reduced 10.16%	4,601,292 $344 Million
Q4 2019 Feb 14, 2020	BUY	$61.62 - $67.78 $50.3 Million - $55.3 Million	815,664 Added 18.94%	5,121,719 $333 Million
Q3 2019 Nov 14, 2019	BUY	$62.51 - $69.0 $8.1 Million - $8.95 Million	129,652 Added 3.1%	4,306,055 $273 Million
Q2 2019 Aug 16, 2019	BUY	$61.87 - $69.38 $7.45 Million - $8.36 Million	120,446 Added 2.97%	4,176,403 $282 Million
Q2 2019 Aug 14, 2019	BUY	$61.87 - $69.38 $3.98 Million - $4.46 Million	64,277 Added 1.61%	4,055,957 $274 Million
Q1 2019 May 15, 2019	SELL	$62.53 - $70.05 $48.8 Million - $54.6 Million	-779,834 Reduced 16.34%	3,991,680 $260 Million
Q4 2018 Feb 14, 2019	BUY	$60.54 - $79.0 $31.8 Million - $41.5 Million	525,858 Added 12.39%	4,771,514 $298 Million
Q3 2018 Nov 14, 2018	SELL	$71.28 - $78.92 $139 Million - $154 Million	-1,949,743 Reduced 31.47%	4,245,656 $328 Million
Q2 2018 Aug 14, 2018	BUY	$64.88 - $75.68 $111 Million - $130 Million	1,713,539 Added 38.23%	6,195,399 $439 Million
Q1 2018 May 15, 2018	SELL	$72.84 - $88.8 $139 Million - $169 Million	-1,901,750 Reduced 29.79%	4,481,860 $338 Million
Q4 2017 Feb 14, 2018	BUY	$71.15 - $83.52 $66.9 Million - $78.6 Million	940,945 Added 17.29%	6,383,610 $457 Million
Q3 2017 Nov 14, 2017	BUY	$72.11 - $85.47 $392 Million - $465 Million	5,442,665	5,442,665 $441 Million

Others Institutions Holding GILD

# of Institutions

1,931

Shares Held

991M

Call Options Held

10.5M

Put Options Held

9.75M

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $113B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.

Account

Susquehanna International Group, LLP Gilead Sciences, Inc. Transaction History